Ignite Creation Date:
2025-12-25 @ 1:10 AM
Ignite Modification Date:
2025-12-25 @ 11:21 PM
Study NCT ID:
NCT04203693
Status:
COMPLETED
Last Update Posted:
2024-07-08
First Post:
2019-12-10
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Observational Study of Tildrakizumab in Patients With Moderate to Severe Plaque Psoriasis in Routine Clinical Practice
Sponsor:
Almirall, S.A.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-10-30
Start Date Type:
ACTUAL
Primary Completion Date:
2024-04-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-04-30
Completion Date Type:
ACTUAL
First Submit Date:
2019-12-10
First Submit QC Date:
None
Study First Post Date:
2019-12-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-05
Last Update Post Date:
2024-07-08
Last Update Post Date Type:
ACTUAL